ClinicalTrials.gg
Status unknownNCT03657303FERARIUpdated Jul 20, 2022

Functional Exercise Response on osteoArthritis Relaxation Imaging

An observational study in Osteoarthritis, sponsored by Cambridge University Hospitals NHS Foundation Trust. Status unknown at 1 site in United Kingdom. Open to participants aged 40 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-20.

Sponsored by Cambridge University Hospitals NHS Foundation Trust · Observational

The sponsor has not verified this record recently (last verified Jul 2022), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
18
Ages
40 Years to 60 Years
Sex
All
01

Study summary

Osteoarthritis (OA) is the most prevalent cause of mobility impairment and disability in the elderly. Indications at early stages of OA include decreased organisation of the collagen matrix, loss of proteoglycans and increased hydration. Late-stage joint disease can be diagnosed with X-ray, CT, and conventional MRI, but there are no validated methods to image early changes in cartilage microstructure, which are direly needed in early phase clinical development. Newly developed therapies and evaluation techniques are required at earlier stages of disease to offset the growing numbers and costs of end-stage disease.

MRI can probe soft-tissue with physical measurements that are not available through other methods. Quantitative MRI signal relaxation properties are particularly promising for assessing early changes in the cartilage composition. These relaxation properties are sensitive to water content and cartilage macromolecular structure.

Mechanical joint-loading and exercise affects quantitative MRI through cartilage compression and nonuniform deformation. A study measuring MRI relaxation times and using static joint-loading weights has shown differences between OA and healthy subjects. Cartilage volume, which is expected to be related to these relaxation times, recovers within an hour after exercise in healthy runners, with the menisci lagging in their volume recovery rate. Previous exercise studies have not measured post-exercise cartilage recovery using compositional techniques, such as physiologically-sensitive T1ρ and T2, nor probed compositional responses with OA subjects.

The investigators will examine a single knee of an initial 18 participants with MR. Participants will be drawn from two groups: (1) 12 participants aged 40-60 years old with clinical and x-ray features of OA and (2) 6 control subjects (matched to cases for age, sex and body mass index in a 1:2 ratio) who do not have clinical features of OA.

Participants will undergo an initial (baseline) MR examination, followed by repeat MR examinations at approximately 1 month and 1 year following the baseline examination.

This will allow the investigators to explore the possibility of mechanical joint-loading and exercise to differentiate early stage OA from healthy subjects and assess both the reliability of the MR measurements and the expected progression in the MR measurements in OA subjects in the absence of any disease-modifying intervention.

02

Conditions studied

  • Osteoarthritis

Keywords

  • Joint Diseases
  • Musculoskeletal Diseases
  • Arthritis
03

In context

Osteoarthritis

4,445 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 18 is below the median of 100 across 803 observational studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Cambridge University Hospitals NHS Foundation Trust is the lead sponsor of 170 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Group 1 will consist of 12 patients aged 40-60 who have presented to the Orthopaedic clinic with a painful knee, and have mild/moderate OA on plain radiographs (Kellgren- Lawrence grade 2-3). Group 2 will consist of 5 healthy volunteer controls, matched (1:2 ratio) to cases for age, sex and body mass index who do not have knee pain.

Eligibility criteria

Group 1 Inclusion Criteria:

  • Meets ACR criteria for OA Kellgren-Lawrence grade 2-3 on knee radiograph
  • Neutral alignment
  • Single symptomatic joint
  • Aged 40-60 years old
  • Ambulatory and in good general health
  • Knee able to fit inside in-vivo knee coil (approx. 18 cm diameter)

Group 2 Inclusion Criteria:

  • No current symptoms of knee pain or stiffness or other clinical features of OA
  • Aged 40-60 years old
  • Written consent to participate in the study
  • Ambulatory and in good general health
  • Knee able to fit inside in-vivo knee coil (approx. 18 cm diameter)

Exclusion Criteria for both groups:

  • History of ipsilateral lower limb fracture
  • History of ipsilateral lower limb surgery (including arthroscopy)
  • Metabolic bone disease
  • Inflammatory arthritis
  • Haematological malignancy
  • Paget's disease
  • Bone metastases
  • Contraindication to MR imaging (e.g. pacemaker, severe claustrophobia)
  • No pregnant patients will be included
  • Unable to consent
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
18 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthy volunteers

    Device: Magnetic resonance imaging (MRI)

  • Osteoarthritis patients

    Device: Magnetic resonance imaging (MRI)

Interventions

  • DeviceMagnetic resonance imaging (MRI)

    Participants will undergo an initial (baseline) MR examination, followed by repeat MR examinations at approximately 1 month and 1 year following the baseline examination.

06

What researchers measure

Primary outcomes

  1. Establish effect sizes for MR parameters in OA patients compared to healthy volunteers.

    Time frame: 1 year

Secondary outcomes

  1. Establish effect sizes for MR parameters in subjects with OA at 1 year compared to baseline.

    Time frame: 1 year

  2. Establish reliability of the MR protocol and analysis techniques.

    Test-Retest Reliability

    Time frame: 1 month - 1 year

07

Study locations

1 site
  • Addenbrooke's Hospital
    Cambridge, Cambridgeshire CB2 0QQ, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 20, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03657303
Responsible party
Professor Fiona J Gilbert (Head of Department - Radiology, Cambridge University Hospitals NHS Foundation Trust) — Principal investigator
First posted
Sep 5, 2018
Start date
Nov 21, 2019
Primary completion
Dec 2022 (estimated)
Completion
Dec 2022 (estimated)
Last update
Jul 20, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion